Senseonics Holdings, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021, at 4:30 p.m. Eastern Time

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE-American: SENS) has announced its plan to release second quarter 2021 financial results on August 9, 2021, after market close. The company will hold a conference call at 4:30 p.m. Eastern Time to discuss its performance, with a concurrent webcast available on their website. Senseonics specializes in developing long-term, implantable continuous glucose monitoring systems, such as the Eversense and Eversense XL, which provide real-time glucose data to users via a smartphone app.

Positive

• Focus on long-term, implantable continuous glucose monitoring systems.
• Eversense products provide real-time glucose data via smartphone.
• Scheduled conference call indicates transparency and engagement with investors.

Negative

• None.

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2021 financial results after market close on Monday, August 9, 2021.

Management will hold a conference call to review the company’s second quarter 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 4998185, approximately ten to five minutes prior to start time.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM Systems, Eversense^® and Eversense^® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005708/en/

FAQ

When will Senseonics release its Q2 2021 financial results?

Senseonics will release its second quarter 2021 financial results on August 9, 2021, after market close.

What time is the Senseonics Q2 2021 conference call?

The conference call to discuss Senseonics' Q2 2021 results will start at 4:30 p.m. Eastern Time on August 9, 2021.

How can I access the Senseonics Q2 2021 earnings call?

The earnings call can be accessed by dialing 1-888-317-6003 for US/Canada or 1-412-317-6061 for International callers, with passcode 4998185.

What products does Senseonics offer for glucose monitoring?

Senseonics offers the Eversense and Eversense XL, long-term, implantable continuous glucose monitoring systems.